Drugs by condition
Drugs approved for fungal infections
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
22
Still marketed, NDA or BLA
Drug classes
4
Novel drugs
8
New molecular entities and new biologics
In development
4
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for fungal infections.
- Micafungin In Sodium Chloride 0.9% (Micafungin Sodium) · Baxter Hlthcare Corp Sep 29, 2023
- Rezzayo (Rezafungin Acetate) · Mundipharma NovelPriority reviewOrphanMar 22, 2023
- Vivjoa (Oteseconazole) · Mycovia Pharms NovelPriority reviewApr 26, 2022
- Noxafil Powdermix Kit (Posaconazole) · Msd Merck CO OrphanMay 31, 2021
- Tolsura (Itraconazole) · Mayne Pharma Dec 11, 2018
All approved drugs for fungal infections, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 132 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Azole Antifungal (12)
- Vivjoa Oteseconazole · Mycovia Pharms · 2022
- Noxafil Posaconazole · Schering · 2006
- Vfend Voriconazole · Pf Prism Cv · 2002
- Sporanox Itraconazole · Janssen Pharms · 1992
- Noxafil Powdermix Kit Posaconazole · Msd Merck CO · 2021
- Tolsura Itraconazole · Mayne Pharma · 2018
- Voriconazole Voriconazole · Hikma · 2017
- Oravig Miconazole · Galt Pharms · 2010
- Terconazole Terconazole · Fougera · 2004
- Vfend Voriconazole · Pf Prism Cv · 2003
- Vfend Voriconazole · Pf Prism Cv · 2002
- Diflucan Fluconazole · Pfizer · 1993
Echinocandin Antifungal (2)
Nucleoside Analog Antifungal (1)
- Ancobon Flucytosine · Bausch · 1971
Class not listed in FDA's data (7)
- Cresemba Isavuconazonium Sulfate · Astellas · 2015
- Micafungin In Sodium Chloride 0.9% Micafungin Sodium · Baxter Hlthcare Corp · 2023
- Caspofungin Acetate Caspofungin Acetate · Fresenius Kabi USA · 2016
- Cresemba Isavuconazonium Sulfate · Astellas · 2015
- Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
- Vusion Miconazole Nitrate, White Petrolatum, Zinc Oxide · Mylan · 2006
- Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
Drugs in development for fungal infections
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- FosmanogepixPhase 32 trials
Basilea Pharmaceutica · Candidemia, Candidiasis, Invasive, Invasive Mold Infections
- OlorofimF901318Phase 32 trials
F2G Ltd · Coccidioidomycosis, Disseminated Fungal Infection, Coccidioides Infection
- TMPSMX, Trimethoprim-sulfamethoxazolePhase 32 trials
Locus Biosciences · Urinary Tract Infections, Candidemia, Mycoses
- HRS9432Phase 21 trial
Fujian Shengdi Pharmaceutical Co., Ltd. · Patients With Candidemia and/or Invasive Candidiasis
3 discontinued brand-name drugs whose label still names it
More on fungal infections: recruiting trials · published research
Related in infectious disease and vaccines: HIV · Hepatitis B · Hepatitis C · COVID-19 · Influenza · RSV · Urinary tract infection · Pneumonia · Skin infections · C. difficile infection
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.